These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 37319011)

  • 21. Unraveling the Dynamics of Omicron (BA.1, BA.2, and BA.5) Waves and Emergence of the Deltacton Variant: Genomic Epidemiology of the SARS-CoV-2 Epidemic in Cyprus (Oct 2021-Oct 2022).
    Chrysostomou AC; Vrancken B; Haralambous C; Alexandrou M; Gregoriou I; Ioannides M; Ioannou C; Kalakouta O; Karagiannis C; Marcou M; Masia C; Mendris M; Papastergiou P; Patsalis PC; Pieridou D; Shammas C; Stylianou DC; Zinieri B; Lemey P; The Comessar Network ; Kostrikis LG
    Viruses; 2023 Sep; 15(9):. PubMed ID: 37766339
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genomic surveillance and vaccine response to the dominant SARS-CoV-2 XBB lineage in Rio Grande do Sul.
    Piccoli BC; Y Castro TR; Tessele LF; Casarin BC; Seerig AP; Vieira AA; Santos VT; Schwarzbold AV; Trindade PA
    Sci Rep; 2024 Jul; 14(1):16831. PubMed ID: 39039137
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidemiological Insights into the Omicron Outbreak via MeltArray-Assisted Real-Time Tracking of SARS-CoV-2 Variants.
    Yan T; Zheng R; Li Y; Sun S; Zeng X; Yue Z; Liao Y; Hu Q; Xu Y; Li Q
    Viruses; 2023 Dec; 15(12):. PubMed ID: 38140638
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early Estimates of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccine Effectiveness Against Symptomatic SARS-CoV-2 Infection Attributable to Co-Circulating Omicron Variants Among Immunocompetent Adults - Increasing Community Access to Testing Program, United States, September 2023-January 2024.
    Link-Gelles R; Ciesla AA; Mak J; Miller JD; Silk BJ; Lambrou AS; Paden CR; Shirk P; Britton A; Smith ZR; Fleming-Dutra KE
    MMWR Morb Mortal Wkly Rep; 2024 Feb; 73(4):77-83. PubMed ID: 38300853
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distinct evolution of SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 lineages combining increased fitness and antibody evasion.
    Planas D; Staropoli I; Michel V; Lemoine F; Donati F; Prot M; Porrot F; Guivel-Benhassine F; Jeyarajah B; Brisebarre A; Dehan O; Avon L; Boland WH; Hubert M; Buchrieser J; Vanhoucke T; Rosenbaum P; Veyer D; Péré H; Lina B; Trouillet-Assant S; ; Hocqueloux L; Prazuck T; Simon-Loriere E; Schwartz O
    bioRxiv; 2024 Feb; ():. PubMed ID: 38045308
    [TBL] [Abstract][Full Text] [Related]  

  • 26. First identification of the SARS-COV-2/XBB.1.5 sublineage among indigenous COVID-19 cases through the influenza sentinel surveillance system in Niger.
    Lagare A; Faye M; Issa M; Hamidou O; Bienvenu B; Mohamed A; Aoula B; Moumouni K; Hassane F; Otto YA; Tambwe DDK; Tassiou EI; Seini H; Faye O; Jambou R
    Heliyon; 2023 Nov; 9(11):e20916. PubMed ID: 37954288
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The rapid rise of SARS-CoV-2 Omicron subvariants with immune evasion properties: XBB.1.5 and BQ.1.1 subvariants.
    Ao D; He X; Hong W; Wei X
    MedComm (2020); 2023 Apr; 4(2):e239. PubMed ID: 36938325
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A regional genomic surveillance program is implemented to monitor the occurrence and emergence of SARS-CoV-2 variants in Yubei District, China.
    Liu F; Deng P; He J; Chen X; Jiang X; Yan Q; Xu J; Hu S; Yan J
    Virol J; 2024 Jan; 21(1):13. PubMed ID: 38191416
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Digital PCR Discriminates between SARS-CoV-2 Omicron Variants and Immune Escape Mutations.
    Holland SC; Holland LA; Smith MF; Lee MB; Hu JC; Lim ES
    Microbiol Spectr; 2023 Aug; 11(4):e0525822. PubMed ID: 37306573
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immune evasion, infectivity, and fusogenicity of SARS-CoV-2 BA.2.86 and FLip variants.
    Qu P; Xu K; Faraone JN; Goodarzi N; Zheng YM; Carlin C; Bednash JS; Horowitz JC; Mallampalli RK; Saif LJ; Oltz EM; Jones D; Gumina RJ; Liu SL
    Cell; 2024 Feb; 187(3):585-595.e6. PubMed ID: 38194968
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Virological characteristics of the SARS-CoV-2 XBB variant derived from recombination of two Omicron subvariants.
    Tamura T; Ito J; Uriu K; Zahradnik J; Kida I; Anraku Y; Nasser H; Shofa M; Oda Y; Lytras S; Nao N; Itakura Y; Deguchi S; Suzuki R; Wang L; Begum MM; Kita S; Yajima H; Sasaki J; Sasaki-Tabata K; Shimizu R; Tsuda M; Kosugi Y; Fujita S; Pan L; Sauter D; Yoshimatsu K; Suzuki S; Asakura H; Nagashima M; Sadamasu K; Yoshimura K; Yamamoto Y; Nagamoto T; Schreiber G; Maenaka K; ; Hashiguchi T; Ikeda T; Fukuhara T; Saito A; Tanaka S; Matsuno K; Takayama K; Sato K
    Nat Commun; 2023 May; 14(1):2800. PubMed ID: 37193706
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Omicron variants of SARS-CoV-2: Epidemiological and clinical insights from a tertiary care center in Saudi Arabia.
    Dubaie B; Aldayel A; Alwethinani S; Alhuthil R; Alhamlan F; Alghamdi S; Alsuhaibani M; Aljumaah S; AlYabes O; AlBanyan E; Al-Hajjar S
    J Infect Public Health; 2024 Jun; 17(6):961-966. PubMed ID: 38608457
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeted amplicon sequencing of wastewater samples for detecting SARS-CoV-2 variants with high sensitivity and resolution.
    Kuroiwa M; Gahara Y; Kato H; Morikawa Y; Matsui Y; Adachi T; Kurosawa S; Kuroita T; Ando Y; Rokushima M
    Sci Total Environ; 2023 Oct; 893():164766. PubMed ID: 37315616
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genomic Surveillance for SARS-CoV-2 Variants Circulating in the United States, December 2020-May 2021.
    Paul P; France AM; Aoki Y; Batra D; Biggerstaff M; Dugan V; Galloway S; Hall AJ; Johansson MA; Kondor RJ; Halpin AL; Lee B; Lee JS; Limbago B; MacNeil A; MacCannell D; Paden CR; Queen K; Reese HE; Retchless AC; Slayton RB; Steele M; Tong S; Walters MS; Wentworth DE; Silk BJ
    MMWR Morb Mortal Wkly Rep; 2021 Jun; 70(23):846-850. PubMed ID: 34111060
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genomic surveillance of SARS-CoV-2 and emergence of XBB.1.16 variant in Rajasthan.
    Sharma P; Gautam S; Sharma A; Parsoya D; Deeba F; Pal N; Singh R; Sharma H; Bhomia N; Sharma RP; Potdar V; Malhotra B
    Indian J Med Microbiol; 2024; 50():100659. PubMed ID: 38945273
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spike Gene Target Amplification in a Diagnostic Assay as a Marker for Public Health Monitoring of Emerging SARS-CoV-2 Variants - United States, November 2021-January 2023.
    Scobie HM; Ali AR; Shirk P; Smith ZR; Paul P; Paden CR; Hassell N; Zheng XY; Lambrou AS; Kondor R; MacCannell D; Thornburg NJ; Miller J; Wentworth D; Silk BJ
    MMWR Morb Mortal Wkly Rep; 2023 Feb; 72(5):125-127. PubMed ID: 36730050
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular insights into the SARS-CoV-2 Omicron variant from Bangladesh suggest diverse and continuous evolution.
    Afrin SZ; Sathi FA; Nooruzzaman M; Parvin R
    Virology; 2023 Oct; 587():109882. PubMed ID: 37757731
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A New-fangled COVID-19 Variant, Eris, Might be the One to Lookout in 2023 or far from Over.
    Ray SK; Mukherjee S
    Infect Disord Drug Targets; 2024; 24(6):e220124225916. PubMed ID: 38258765
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circulation of SARS-CoV-2 Omicron sub-lineages revealed by multiplex genotyping RT-qPCR assays for sewage surveillance.
    Ding J; Xu X; Deng Y; Zheng X; Zhang T
    Sci Total Environ; 2023 Dec; 904():166300. PubMed ID: 37591390
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Real-world use of nirmatrelvir-ritonavir in COVID-19 outpatients during BQ.1, BQ.1.1., and XBB.1.5 predominant omicron variants in three U.S. health systems: a retrospective cohort study.
    Aggarwal NR; Beaty LE; Bennett TD; Fish LE; Jacobs JR; Mayer DA; Molina KC; Peers JL; Richardson DB; Russell S; Varela A; Webb BJ; Wynia MK; Xiao M; Carlson NE; Ginde AA
    Lancet Reg Health Am; 2024 Mar; 31():100693. PubMed ID: 38500962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.